Metabolic syndrome, diabetes, and hyperuricemia
PURPOSE OF REVIEWTo explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. RECENT FINDINGSThe prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with...
Gespeichert in:
Veröffentlicht in: | Current opinion in rheumatology 2013-03, Vol.25 (2), p.210-216 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 216 |
---|---|
container_issue | 2 |
container_start_page | 210 |
container_title | Current opinion in rheumatology |
container_volume | 25 |
creator | Li, Changgui Hsieh, Ming-Chia Chang, Shun-Jen |
description | PURPOSE OF REVIEWTo explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia.
RECENT FINDINGSThe prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with hyperuricemia compared with normouricemia. Even in those with normouricemia, higher serum uric acid levels were associated with metabolic syndrome. Serum uric acid was an independent risk factor for incident diabetes, and evidence showed that the patients with both gout and type 2 diabetes exhibited a mutual inter-dependent effect on higher incidences. Furthermore, obese patients often demonstrated insulin resistance and adipose tissue macrophage with low-grade inflammation, which is suggested to be the major contributor. Although alcohol intake is considered a risk for developing hyperuricemia, moderate alcohol intake showed a lower risk for developing type 2 diabetes and insulin resistance. Hyperinsulinemia reduces renal excretion of uric acid on the proximal tubular of the kidney leading to hyperuricemia, which has deleterious effects on endothelial function and on nitric oxide bioavailability, thus causing hyperinsulinemia.
SUMMARYWe found evidence to suggest that insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect. |
doi_str_mv | 10.1097/BOR.0b013e32835d951e |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1283732783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1283732783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3520-6ed89c819f68dbb4ccf70ebf84877f01128393707deb268ddaa85044a037a4b03</originalsourceid><addsrcrecordid>eNpdUF1Lw0AQPESxtfoPRProQ9Pu3SW5y6MWv6BSEH0-7mNDo0lT7xJK_71XrAouLLsLM7PDEHJJYUqhELPb5csUDFCOnEmeuSKjeESGNOM0yYucH8cdUkikoHRAzkJ4B6CsoOyUDBjnArhIh2T2jJ02bV3ZcditnW8bnIxdpQ12GCZjvXbj1W6DvveVxabS5-Sk1HXAi8Mckbf7u9f5Y7JYPjzNbxaJ5RmDJEcnCytpUebSGZNaWwpAU8pUClECpdFyET0Ih4ZFiNNaZpCmOrrSqQE-ItffuhvffvYYOtVUwWJd6zW2fVB7AcGZkDxC02-o9W0IHku18VWj_U5RUPuoVIxK_Y8q0q4OH3rToPsl_WTzp7tt6w59-Kj7LXq1Ql13KwWxGJM0YVEXeLyS2BT4F5DHc6A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1283732783</pqid></control><display><type>article</type><title>Metabolic syndrome, diabetes, and hyperuricemia</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Li, Changgui ; Hsieh, Ming-Chia ; Chang, Shun-Jen</creator><creatorcontrib>Li, Changgui ; Hsieh, Ming-Chia ; Chang, Shun-Jen</creatorcontrib><description>PURPOSE OF REVIEWTo explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia.
RECENT FINDINGSThe prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with hyperuricemia compared with normouricemia. Even in those with normouricemia, higher serum uric acid levels were associated with metabolic syndrome. Serum uric acid was an independent risk factor for incident diabetes, and evidence showed that the patients with both gout and type 2 diabetes exhibited a mutual inter-dependent effect on higher incidences. Furthermore, obese patients often demonstrated insulin resistance and adipose tissue macrophage with low-grade inflammation, which is suggested to be the major contributor. Although alcohol intake is considered a risk for developing hyperuricemia, moderate alcohol intake showed a lower risk for developing type 2 diabetes and insulin resistance. Hyperinsulinemia reduces renal excretion of uric acid on the proximal tubular of the kidney leading to hyperuricemia, which has deleterious effects on endothelial function and on nitric oxide bioavailability, thus causing hyperinsulinemia.
SUMMARYWe found evidence to suggest that insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect.</description><identifier>ISSN: 1040-8711</identifier><identifier>EISSN: 1531-6963</identifier><identifier>DOI: 10.1097/BOR.0b013e32835d951e</identifier><identifier>PMID: 23370374</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, Inc</publisher><subject>Adult ; Alcohol Drinking - adverse effects ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - etiology ; Humans ; Hyperuricemia - complications ; Hyperuricemia - epidemiology ; Hyperuricemia - etiology ; Insulin Resistance ; Male ; Metabolic Syndrome - complications ; Metabolic Syndrome - epidemiology ; Metabolic Syndrome - etiology ; Obesity - complications ; Prevalence ; Risk Factors</subject><ispartof>Current opinion in rheumatology, 2013-03, Vol.25 (2), p.210-216</ispartof><rights>2013 Lippincott Williams & Wilkins, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3520-6ed89c819f68dbb4ccf70ebf84877f01128393707deb268ddaa85044a037a4b03</citedby><cites>FETCH-LOGICAL-c3520-6ed89c819f68dbb4ccf70ebf84877f01128393707deb268ddaa85044a037a4b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23370374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Changgui</creatorcontrib><creatorcontrib>Hsieh, Ming-Chia</creatorcontrib><creatorcontrib>Chang, Shun-Jen</creatorcontrib><title>Metabolic syndrome, diabetes, and hyperuricemia</title><title>Current opinion in rheumatology</title><addtitle>Curr Opin Rheumatol</addtitle><description>PURPOSE OF REVIEWTo explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia.
RECENT FINDINGSThe prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with hyperuricemia compared with normouricemia. Even in those with normouricemia, higher serum uric acid levels were associated with metabolic syndrome. Serum uric acid was an independent risk factor for incident diabetes, and evidence showed that the patients with both gout and type 2 diabetes exhibited a mutual inter-dependent effect on higher incidences. Furthermore, obese patients often demonstrated insulin resistance and adipose tissue macrophage with low-grade inflammation, which is suggested to be the major contributor. Although alcohol intake is considered a risk for developing hyperuricemia, moderate alcohol intake showed a lower risk for developing type 2 diabetes and insulin resistance. Hyperinsulinemia reduces renal excretion of uric acid on the proximal tubular of the kidney leading to hyperuricemia, which has deleterious effects on endothelial function and on nitric oxide bioavailability, thus causing hyperinsulinemia.
SUMMARYWe found evidence to suggest that insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect.</description><subject>Adult</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - etiology</subject><subject>Humans</subject><subject>Hyperuricemia - complications</subject><subject>Hyperuricemia - epidemiology</subject><subject>Hyperuricemia - etiology</subject><subject>Insulin Resistance</subject><subject>Male</subject><subject>Metabolic Syndrome - complications</subject><subject>Metabolic Syndrome - epidemiology</subject><subject>Metabolic Syndrome - etiology</subject><subject>Obesity - complications</subject><subject>Prevalence</subject><subject>Risk Factors</subject><issn>1040-8711</issn><issn>1531-6963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUF1Lw0AQPESxtfoPRProQ9Pu3SW5y6MWv6BSEH0-7mNDo0lT7xJK_71XrAouLLsLM7PDEHJJYUqhELPb5csUDFCOnEmeuSKjeESGNOM0yYucH8cdUkikoHRAzkJ4B6CsoOyUDBjnArhIh2T2jJ02bV3ZcditnW8bnIxdpQ12GCZjvXbj1W6DvveVxabS5-Sk1HXAi8Mckbf7u9f5Y7JYPjzNbxaJ5RmDJEcnCytpUebSGZNaWwpAU8pUClECpdFyET0Ih4ZFiNNaZpCmOrrSqQE-ItffuhvffvYYOtVUwWJd6zW2fVB7AcGZkDxC02-o9W0IHku18VWj_U5RUPuoVIxK_Y8q0q4OH3rToPsl_WTzp7tt6w59-Kj7LXq1Ql13KwWxGJM0YVEXeLyS2BT4F5DHc6A</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Li, Changgui</creator><creator>Hsieh, Ming-Chia</creator><creator>Chang, Shun-Jen</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201303</creationdate><title>Metabolic syndrome, diabetes, and hyperuricemia</title><author>Li, Changgui ; Hsieh, Ming-Chia ; Chang, Shun-Jen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3520-6ed89c819f68dbb4ccf70ebf84877f01128393707deb268ddaa85044a037a4b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - etiology</topic><topic>Humans</topic><topic>Hyperuricemia - complications</topic><topic>Hyperuricemia - epidemiology</topic><topic>Hyperuricemia - etiology</topic><topic>Insulin Resistance</topic><topic>Male</topic><topic>Metabolic Syndrome - complications</topic><topic>Metabolic Syndrome - epidemiology</topic><topic>Metabolic Syndrome - etiology</topic><topic>Obesity - complications</topic><topic>Prevalence</topic><topic>Risk Factors</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Changgui</creatorcontrib><creatorcontrib>Hsieh, Ming-Chia</creatorcontrib><creatorcontrib>Chang, Shun-Jen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Changgui</au><au>Hsieh, Ming-Chia</au><au>Chang, Shun-Jen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic syndrome, diabetes, and hyperuricemia</atitle><jtitle>Current opinion in rheumatology</jtitle><addtitle>Curr Opin Rheumatol</addtitle><date>2013-03</date><risdate>2013</risdate><volume>25</volume><issue>2</issue><spage>210</spage><epage>216</epage><pages>210-216</pages><issn>1040-8711</issn><eissn>1531-6963</eissn><abstract>PURPOSE OF REVIEWTo explore the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia.
RECENT FINDINGSThe prevalence of hyperuricemia in male adults with metabolic syndrome was increased and a large difference in prevalence of metabolic syndrome also existed in those with hyperuricemia compared with normouricemia. Even in those with normouricemia, higher serum uric acid levels were associated with metabolic syndrome. Serum uric acid was an independent risk factor for incident diabetes, and evidence showed that the patients with both gout and type 2 diabetes exhibited a mutual inter-dependent effect on higher incidences. Furthermore, obese patients often demonstrated insulin resistance and adipose tissue macrophage with low-grade inflammation, which is suggested to be the major contributor. Although alcohol intake is considered a risk for developing hyperuricemia, moderate alcohol intake showed a lower risk for developing type 2 diabetes and insulin resistance. Hyperinsulinemia reduces renal excretion of uric acid on the proximal tubular of the kidney leading to hyperuricemia, which has deleterious effects on endothelial function and on nitric oxide bioavailability, thus causing hyperinsulinemia.
SUMMARYWe found evidence to suggest that insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>23370374</pmid><doi>10.1097/BOR.0b013e32835d951e</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1040-8711 |
ispartof | Current opinion in rheumatology, 2013-03, Vol.25 (2), p.210-216 |
issn | 1040-8711 1531-6963 |
language | eng |
recordid | cdi_proquest_miscellaneous_1283732783 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adult Alcohol Drinking - adverse effects Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - etiology Humans Hyperuricemia - complications Hyperuricemia - epidemiology Hyperuricemia - etiology Insulin Resistance Male Metabolic Syndrome - complications Metabolic Syndrome - epidemiology Metabolic Syndrome - etiology Obesity - complications Prevalence Risk Factors |
title | Metabolic syndrome, diabetes, and hyperuricemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T06%3A01%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20syndrome,%20diabetes,%20and%20hyperuricemia&rft.jtitle=Current%20opinion%20in%20rheumatology&rft.au=Li,%20Changgui&rft.date=2013-03&rft.volume=25&rft.issue=2&rft.spage=210&rft.epage=216&rft.pages=210-216&rft.issn=1040-8711&rft.eissn=1531-6963&rft_id=info:doi/10.1097/BOR.0b013e32835d951e&rft_dat=%3Cproquest_cross%3E1283732783%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1283732783&rft_id=info:pmid/23370374&rfr_iscdi=true |